Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients
- Status
- UNKNOWN
- Phase
- N/A
Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Single Dose of Pembrolizumab in HIV-Infected People
- Status
- TERMINATED
- Phase
- PHASE1
Breast Cancer Study of Preoperative Pembrolizumab + Radiation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002)
- Status
- COMPLETED
- Phase
- PHASE1
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)
- Status
- COMPLETED
- Phase
- PHASE3
Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- Status
- COMPLETED
- Phase
- PHASE3
DPX-Survivac and Checkpoint Inhibitor in DLBCL
- Status
- COMPLETED
- Phase
- PHASE2
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
- Status
- COMPLETED
- Phase
- PHASE1
Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab as Neoadjuvant Treatment in HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2